Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec 28;20(48):18177-88.
doi: 10.3748/wjg.v20.i48.18177.

Role of interleukin-22 in inflammatory bowel disease

Affiliations
Review

Role of interleukin-22 in inflammatory bowel disease

Lin-Jing Li et al. World J Gastroenterol. .

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease thought to be mediated by the microbiota of the intestinal lumen and inappropriate immune responses. Aberrant immune responses can cause secretion of harmful cytokines that destroy the epithelium of the gastrointestinal tract, leading to further inflammation. Interleukin (IL)-22 is a member of the IL-10 family of cytokines that was recently discovered to be mainly produced by both adaptive and innate immune cells. Several cytokines and many of the transcriptional factors and T regulatory cells are known to regulate IL-22 expression through activation of signal transducer and activator of transcription 3 signaling cascades. This cytokine induces antimicrobial molecules and proliferative and antiapoptotic pathways, which help prevent tissue damage and aid in its repair. All of these processes play a beneficial role in IBD by enhancing intestinal barrier integrity and epithelial innate immunity. In this review, we discuss recent progress in the involvement of IL-22 in the pathogenesis of IBD, as well as its therapeutic potential.

Keywords: Inflammatory bowel disease; Interleukin-22; Signal transducer and activator of transcription 3.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interleukin-22 signaling pathway. IL-22 binds to a heterodimeric receptor composed of IL-10R2 and IL-22R1, activating JAK1 and TYK2, which self-phosphorylate, resulting in binding and phosphorylation of STAT3. Then, STAT3 translocates to the nucleus and induces target genes. IL: Interleukin; JAK: Janus kinase; TYK: Tyrosine protein kinase; STAT: Signal transducer and activator of transcription.
Figure 2
Figure 2
Protective function of interleukin-22 in inflammatory bowel disease. In the intestine, innate and adaptive immune cells, cytokines and many of the transcriptional factors can induce and regulate expression of IL-22. Through activation of STAT3 signaling cascades, IL-22 induces antimicrobial molecules and proliferative and antiapoptotic pathways, and helps regenerate goblet cells and produce mucin proteins, which could prevent tissue damage and aid in its repair. IL: Interleukin; STAT: Signal transducer and activator of transcription.

Similar articles

Cited by

References

    1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429. - PubMed
    1. Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362–381. - PubMed
    1. Sonnenberg GF, Fouser LA, Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol. 2010;107:1–29. - PubMed
    1. Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev. 2010;21:435–441. - PubMed
    1. Aujla SJ, Kolls JK. IL-22: a critical mediator in mucosal host defense. J Mol Med (Berl) 2009;87:451–454. - PubMed

Publication types

MeSH terms